Mycobacterium tuberculosis, the causative agent of tuberculosis, produces toxins and their antidotes to regulate its growth ...

Visitors arriving in Glasgow, UK, today are met with a city that's undergone massive regeneration, from the colourfully ...

Quabodepistat is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Pulmonary Tuberculosis.